ClearPoint Neuro (CLPT) Interest Coverage Ratio (QoQ) (2011 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -26.73% |
| Mar 31, 2022 | -50.13% |
| Dec 31, 2021 | -51.91% |
| Sep 30, 2021 | -12.59% |
| Jun 30, 2021 | -116.09% |
| Mar 31, 2021 | 40.83% |
| Dec 31, 2020 | -75.45% |
| Sep 30, 2020 | 15.48% |
| Jun 30, 2020 | -421.45% |
| Mar 31, 2020 | 76.84% |
| Dec 31, 2019 | -45.16% |
| Sep 30, 2019 | 14.44% |
| Jun 30, 2019 | -30.47% |
| Mar 31, 2019 | 6.99% |
| Dec 31, 2018 | 15.82% |
| Sep 30, 2018 | 25.89% |
| Jun 30, 2018 | -14.35% |
| Sep 30, 2016 | 12.82% |
| Jun 30, 2016 | -46.02% |
| Sep 30, 2015 | 29.34% |
| Jun 30, 2015 | 9.99% |
| Mar 31, 2015 | -5.33% |
| Dec 31, 2014 | -0.18% |
| Sep 30, 2014 | -16.10% |
| Jun 30, 2014 | -153.94% |
| Mar 31, 2014 | 795.15% |
| Dec 31, 2013 | 85.71% |
| Sep 30, 2013 | 13.19% |
| Jun 30, 2013 | -1,565.73% |
| Mar 31, 2013 | 81.73% |
| Dec 31, 2012 | 53.44% |
| Sep 30, 2012 | -137.27% |
| Jun 30, 2012 | -908.74% |
| Mar 31, 2012 | 75.38% |
| Dec 31, 2011 | 0.77% |
| Sep 30, 2011 | 17.60% |
| Jun 30, 2011 | 21.94% |